TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IMMX

Immix Biopharma Inc

Healthcare · Biotechnology

11.70$ -1.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMMX
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +114.5% +6.3% -13.5% +156.1% +2,010.2% +215.9%
– – – +185.0% +311.1% +17.7% -19.2%
– +0.0% +3,921.7% -97.3% – – –
– -8.7% -335.8% – +746.8% +140.0% -31.9%
– -99.9% +19,950.0% -99.6% +1,736,200.0% +2,160.9% -37.8%
– -89.0% +0.0% – – +2,160.9% +512.5%
– – – – -56.0% – –
– -81.0% +0.0% -125.0% -100.0% – –
– +1,695.1% +0.0% -82.9% +378.4% +3.1% +573.3%
– -226.2% – -124.4% – -95.8% +44,187.5%
– – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?